Falsified Data in Clinical Trials How to Determine What to Report to the FDA

To learn more about this controversial proposal, sign up today for the FDAnews webinar, Falsified Data in Clinical Trials: How to Determine What to Report to the FDA, being held on Tuesday, May 18, 2010.

We’ve engaged two top experts with who have the unique backgrounds needed to thoroughly discuss the proposal. David Clissold has conducted clinical and pre-clinical research at Nova Pharmaceuticals and Johns Hopkins School of Medicine; Nisha Shah is an analyst who has developed economic models of cost-effectiveness and cost benefits of pharma products. Both Clissold and Shah are attorneys, currently practicing at the law firm of Hyman, Phelps & McNamara. Their combined experience provides them with a unique perspective — one that’s sure to be invaluable to attendees of this session.


Audio CD/Transcript - May 18, 2010 The Audio CD/Transcript will be shipped the week of June 15, 2010.